Insulin detemir Subcutaneous and Posaconazole Delayed-Release Tablets
Determining the interaction of Insulin detemir Subcutaneous and Posaconazole Delayed-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Posaconazole (oral/injection), Posaconazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin detemir Subcutaneous-Posaconazole Injection
- Insulin detemir Subcutaneous-Posaconazole Intravenous
- Insulin detemir Subcutaneous-Posaconazole Oral Suspension
- Insulin detemir Subcutaneous-Posaconazole oral/injection
- Insulin detemir Subcutaneous-Posaconazole Tablets
- Insulin detemir Subcutaneous-PosiFlush flush
- Posaconazole Delayed-Release Tablets-Insulin glargine
- Posaconazole Delayed-Release Tablets-Insulin Glargine (U-100) Cartridge Systems and Pens
- Posaconazole Delayed-Release Tablets-Insulin Glargine (U-100) Vials
- Posaconazole Delayed-Release Tablets-Insulin Glargine (U-300) Pens
- Posaconazole Delayed-Release Tablets-Insulin glargine and lixisenatide
- Posaconazole Delayed-Release Tablets-Insulin glargine and lixisenatide Subcutaneous